Riyadh's MedTech Mandate: Pure Global on SFDA's Supply Chain Shockwave. Podcast By cover art

Riyadh's MedTech Mandate: Pure Global on SFDA's Supply Chain Shockwave.

Riyadh's MedTech Mandate: Pure Global on SFDA's Supply Chain Shockwave.

Listen for free

View show details
This week on MENA MedTech Insights, we dive into the most critical regulatory shift happening in the region right now. The Saudi Food and Drug Authority (SFDA) has ended its grace period and is now fully enforcing its complex new track-and-trace regulations for all medical devices. This move is creating immediate and significant disruptions for international manufacturers and distributors. We explore the specific technical requirements of the new system, from Unique Device Identification (UDI) mandates to the digital labeling protocols causing widespread confusion. We break down why so many companies were unprepared for the strict enforcement and what the most common points of failure are at customs, leading to costly delays and potential loss of market access. A specific case we analyze involves a European diagnostics company that had a critical shipment of testing kits held at Riyadh port for over a week. The reason? A subtle mismatch between the digital barcode data uploaded to the SFDA's portal and the physical label on the packaging. This small error jeopardized a major hospital contract and highlights the immense financial risk of non-compliance. This week's key takeaways: 1. What are the exact details of the SFDA's newly enforced track-and-trace regulations?. 2. Why are these rules causing unexpected shipment delays for even experienced MedTech exporters?. 3. How can a minor labeling error put your entire Saudi market presence at risk?. 4. Is this regulatory shift a deliberate move by Saudi Arabia to raise the barrier to market entry?. 5. What are the immediate, critical actions your company must take to avoid compliance failures?. 6. How does the SFDA's UDI system compare to regulations in the US and EU?. 7. What specific questions should you be asking your local Saudi representative or distributor right now?. 8. Beyond labeling, which technical dossier documents are now under intense scrutiny?. Navigating the complexities of market access in key MENA markets like Saudi Arabia is more challenging than ever. Pure Global offers end-to-end regulatory consulting solutions for MedTech and IVD companies, combining deep local expertise with advanced AI tools to streamline SFDA registration and ensure ongoing compliance. From developing your regulatory strategy to acting as your official in-country representative, we make global market access seamless. Contact us at info@pureglobal.com or visit https://pureglobal.com to learn more.
No reviews yet